Anti-Entamoeba (ENTH-0504)

Anti-Entamoeba (ENTH-0504)

Product No.: E164

- -
- -
Formats AvailableView All
Product Type
Hybridoma Monoclonal Antibody
Mouse IgG2b
Lateral Flow

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactivity Species
E. dispar
E. histolytica
Host Species
Product Concentration
≥1.0 mg/ml
Formulated in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1% sodium azide. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
State of Matter
Product Preparation
This monoclonal antibody is purified by protein A chromatography or sequential differential precipitations.
Storage and Handling
This purified antibody is stable when stored at 2-8°C. Do not freeze.
Regulatory Status
Research Use Only
Country of Origin
2-8°C Wet Ice
Applications and Recommended Usage?
Quality Tested by Leinco
ELISA: 1:20-1:200
Additional Applications Reported In Literature ?
Lateral Flow
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.


Anti-Entamoeba (Clone ENTH-0504) is specific for E. histolytica and E. dispar
Matched Pair
Best ELISA pair (capture/detection), ENTH-0504/ENTH-7620
Entamoeba histolytica is a pathogenic amoeba that causes amebiasis, a significant intestinal and extra-intestinal infection in humans. It is a single-celled protozoan parasite belonging to the Entamoeba genus. Infection occurs through the ingestion of cysts, the dormant and infective stage of the parasite, found in contaminated food or water. Once inside the human host, the cysts release trophozoites, the active form of the parasite, which colonize the large intestine and can cause diarrhea, abdominal pain, and other gastrointestinal symptoms. In some cases, E. histolytica can penetrate the intestinal wall, leading to the formation of liver abscesses and extra-intestinal manifestations. The disease is especially prevalent in areas with poor sanitation and limited access to clean water. Proper sanitation, personal hygiene, and water purification are crucial in preventing the transmission of E. histolytica and reducing the burden of amebiasis worldwide.

Antigen Details

Research Area
Category B Pathogens
Infectious Disease
Matched Pair
IVD Raw Material

References & Citations

1. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED)
Indirect Elisa Protocol
Lateral Flow

Formats Available

- -
- -
Prod No.
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.